SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

That was a follow up to this analyst

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cjstocksup Member Profile
Member Level 
Followed By 2,879
Posts 207,903
Boards Moderated 1
Alias Born 07/30/07
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/11/2017 8:01:50 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:09:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:08:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:07:22 PM
Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development "NetworkNewsWire" - 9/28/2017 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/28/2017 7:02:33 AM
Zynerba Pharmaceuticals Announces Positive Top Line Results in ZYN002 Open Label Phase 2 FAB-C Study in Children with Fragile... "GlobeNewswire Inc." - 9/28/2017 6:30:00 AM
Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development "NetworkNewsWire" - 9/26/2017 8:45:00 AM
Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects "NetworkNewsWire" - 9/19/2017 8:45:00 AM
Biosynthesis Technology Could Transform Cannabinoid Production "NetworkNewsWire" - 9/13/2017 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 5:02:12 PM
Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences "GlobeNewswire Inc." - 9/6/2017 7:30:00 AM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing "InvestorsHub NewsWire" - 8/30/2017 10:29:33 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 "InvestorsHub NewsWire" - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code "InvestorsHub NewsWire" - 8/25/2017 6:50:56 PM
Book your ticket now for InvestorsHubs International Cannabis Conference "InvestorsHub NewsWire" - 8/23/2017 12:50:25 PM
MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market "InvestorsHub NewsWire" - 8/22/2017 1:27:13 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/14/2017 7:03:20 AM
Zynerba Pharmaceuticals Announces that Results from Phase 2 STOP Trial Support Continued Development of ZYN002 in Osteoarthri... "GlobeNewswire Inc." - 8/14/2017 6:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 7:01:10 AM
Zynerba Pharmaceuticals Announces Top-Line Results from Phase 2 STAR 1 Trial of ZYN002 in Adult Epilepsy Patients with Focal ... "GlobeNewswire Inc." - 8/7/2017 6:45:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/1/2017 4:19:17 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/1/2017 7:31:42 AM
Zynerba Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights "GlobeNewswire Inc." - 8/1/2017 7:30:00 AM
cjstocksup Member Level  Tuesday, 10/03/17 12:53:46 AM
Re: cjstocksup post# 901
Post # of 965 
That was a follow up to this analyst upgrade to Overweight and $17.00 per share ZYNE PPS target.
ZYNE upgraded to $17.00. Look for more of these.
UPDATE: Cantor Fitzgerald Upgrades Zynerba Pharmaceuticals (ZYNE) to Overweight
October 2, 2017 5:55 AM

(Updated - October 2, 2017 6:54 AM EDT)


(updated to add analyst comment)

Cantor Fitzgerald upgraded Zynerba Pharmaceuticals (NASDAQ: ZYNE) from Neutral to Overweight with a price target of $17.00 (from $4.00).

Analyst Elemer Piros cites the phase 2a data in Fragile X syndrome noting encouragement from the potential for ZYN002 in treating the disease. The analyst sees upside catalysts from additional regulatory clarity on late-stage development which is slated for 2018.

For an analyst ratings summary and ratings history on Zynerba Pharmaceuticals click here. For more ratings news on Zynerba Pharmaceuticals click here.

Shares of Zynerba Pharmaceuticals closed at $8.36 Friday.
https://www.streetinsider.com/dr/news.php?id=13346899&gfv=1


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist